Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train

A California biotech with a chronic pain drug that's long been approved in Italy, but not the US, is going onto the public markets through the increasingly popular reverse merger route. Ambros ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 21 August →